Doximity IncDOCS
Price$28.50Intrinsic value$33.0416% above price

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $655.6M+14.9% YoYTTM through 30 Jun 2026
Net Income $167M-25.2% YoYTTM through 30 Jun 2026
Free Cash Flow $306.3MTTM through 30 Jun 2026

Margins

Current
Gross Margin89.1%
EBITDA Margin32.0%
Operating Margin33.3%
Net Margin25.5%

Returns

20.6%ROE
17.4%ROA
20.6%ROIC

Balance Sheet Health

Debt / Equity0.00x
Current Ratio6.09x
Net Debt-$748.6Mnet cash position
Cash & Equivalents$273.6M

Quality Metrics

Altman Z-Score18.79
Piotroski F-Score5 / 9
FCF Margin46.7%
Rule of 4049.9
Earnings-Beat Rate75.0%

Multi-Year Trend

Revenue
'20'21'22'23'24'25'26
FY2026: $644.9M
Diluted EPS$0.84TTM
'20'21'22'23'24'25'26
FY2026: $0.98

Dividend

No dividend

Capital Allocation

R&D Spend$142.4M
Capex Intensity9,457.4%

Segment Performance

No segment data available.

All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.